We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.06%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.11T
AUM Growth
+$49.3B
Cap. Flow
-$2.91B
Cap. Flow %
-0.26%
Top 10 Hldgs %
27.74%
Holding
3,121
New
186
Increased
817
Reduced
1,825
Closed
148

Top Buys

Rank Stock Value
1
RIVN icon
Rivian
RIVN
+$18.7B
2
AAPL icon
Apple
AAPL
+$5.48B
3
NVDA icon
NVIDIA
NVDA
+$5.33B
4
TSLA icon
Tesla
TSLA
+$4.47B
5
MSFT icon
Microsoft
MSFT
+$2.15B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$4.26B
2
META icon
Meta Platforms (Facebook)
META
+$3.3B
3
MS icon
Morgan Stanley
MS
+$2.82B
4
GPN icon
Global Payments
GPN
+$2.43B
5
PYPL icon
PayPal
PYPL
+$2B

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Healthcare 16.09%
3 Consumer Discretionary 15.79%
4 Communication Services 12.38%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INMD icon
2701
InMode
INMD
$875M
$226K ﹤0.01%
+3,200
New +$257K
PAHC icon
2702
Phibro Animal Health
PAHC
$1.38B
$225K ﹤0.01%
11,019
-321
-3% -$6.85K
XLY icon
2703
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.5B
$225K ﹤0.01%
+2,200
New +$219K
BLFS icon
2704
BioLife Solutions
BLFS
$1.72B
$222K ﹤0.01%
+5,962
New +$256K
FUSB icon
2705
First US Bancshares
FUSB
$90.7M
$222K ﹤0.01%
20,950
NGS icon
2706
Natural Gas Services Group
NGS
$474M
$222K ﹤0.01%
21,188
ARC
2707
DELISTED
ARC Document Solutions, Inc.
ARC
$222K ﹤0.01%
63,502
MMAT
2708
DELISTED
Meta Materials Inc. Common Stock
MMAT
$221K ﹤0.01%
900
-44
-5% -$18.1K
DBD
2709
DELISTED
Diebold Nixdorf Incorporated
DBD
$221K ﹤0.01%
24,462
-1,300
-5% -$12.1K
MRTN icon
2710
Marten Transport
MRTN
$1.24B
$220K ﹤0.01%
12,807
-1,015
-7% -$16.8K
VERV
2711
DELISTED
Verve Therapeutics
VERV
$220K ﹤0.01%
+5,969
New +$251K
ASXC
2712
DELISTED
Asensus Surgical, Inc.
ASXC
$220K ﹤0.01%
197,841
+71,000
+56% +$110K
CARM
2713
DELISTED
Carisma Therapeutics
CARM
$219K ﹤0.01%
13,445
+10,647
+381% +$214K
EUCR
2714
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$219K ﹤0.01%
22,427
+2,127
+10% +$20.8K
PBIP
2715
DELISTED
Prudential Bancorp, Inc.
PBIP
$218K ﹤0.01%
16,085
AGPU
2716
Axe Compute Inc
AGPU
$96M
$217K ﹤0.01%
760
+202
+36% +$67.9K
AUY
2717
DELISTED
Yamana Gold, Inc.
AUY
$217K ﹤0.01%
51,600
-29
-0.1% -$120
ROCC
2718
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$216K ﹤0.01%
8,008
+89
+1% +$2.62K
BBSI icon
2719
Barrett Business Services
BBSI
$800M
$215K ﹤0.01%
12,436
-5,304
-30% -$101K
VITL icon
2720
Vital Farms
VITL
$498M
$214K ﹤0.01%
+11,868
New +$209K
INBK icon
2721
First Internet Bancorp
INBK
$256M
$213K ﹤0.01%
+4,527
New +$183K
IWV icon
2722
iShares Russell 3000 ETF
IWV
$20.6B
$212K ﹤0.01%
+764
New +$207K
KALA icon
2723
KALA BIO
KALA
$17.9M
$211K ﹤0.01%
70
+16
+30% +$74.2K
NDLS icon
2724
Noodles & Co
NDLS
$100M
$211K ﹤0.01%
2,910
-100
-3% -$9.1K
WFRD icon
2725
Weatherford International
WFRD
$6.6B
$211K ﹤0.01%
+7,600
New +$208K

Similar funds

T. Rowe Price Associates's Q4 2021 Portfolio in Review

As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.

T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
  • T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
  • T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
  • T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
  • T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
  • T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
  • T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.